IL6 and metabolic syndrome: Generally speaking, the accumulation of visceral fat due to metabolic syndrome will lead to over-expression of adipokines, such as resistin, IL-6, and TNF-α, resulting in diminish eNOS activity, less NO generation and endothelial dysfunction [34].